Stock screenerAll disclosures →
EDGAR →
GPCR
Conviction 8HealthcareScan · Thu, Sep 24, 2026Structure Therapeutics Inc. (GPCR) closed at $36.04 (+0.25%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 29, RS Rating 93, -61.6% from its 52-week high, -47.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
GPCR$36.04+0.25%
ResistanceSupportVol 14Insider sell3
3
2
2
Vol MA14 1.32M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price36.04
Change+0.25%
Gap-1.28%
Rel volume0.68×
Avg volume1.16M
Avg $ vol46.52M
SMA 2041.03
SMA 5046.72
SMA 20054.59
Price vs 50-22.86%
Price vs 200-33.97%
MA stackbearish
50/200 cross—
Supertrenddown · 41.97
RSI (14)29
MACD hist-0.26
MACD cross—
Stoch %K / %D12 / 14
ADX (14)39
+DI / −DI11 / 33
RSI divergence—
MACD divergence—
ATR %6.30%
ADR %5.69%
52w high93.79
52w low24.99
From 52w high-61.57%
Above 52w low+44.22%
New 52w highNo
SqueezeOff
Bollinger width48.78%
%B0.25
Donchian pos10.56%
Donchian high49.81
Donchian low34.42
AVWAP (52w high)57.51
vs AVWAP high-37.33%
AVWAP (52w low)52.10
vs AVWAP low-30.82%
OBV trendDown
Chaikin MF (20)-0.26
Today vs 20d0.68×
Avg vol (14d)1.32M
Avg vol (20d)1.16M
Avg $ vol (20d)46.52M
Market cap2.56B
RS Rating93 / 99
RS 3m (vs SPY)-29.80%
RS 6m (vs SPY)-41.94%
RS line new highNo
Trend template2/8
Technical rank11.0
1 week+2.68%
1 month-27.80%
3 months-25.31%
6 months-25.12%
1 year+50.10%
YTD-47.09%
P/E-18.14
P/B1.89
P/S—
P/FCF-11.34
EPS-0.8000
Div yield—
ROE-10.43%
ROA-9.91%
Debt/Eq—
Current20.75
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-15.24%
Price target108.46
Target upside200.94%
Analyst ratingBuy
Institutional34.56%
Ent. value2.29B
Revenue—
Net income-106.16M
Gross profit—
Free cash flow-225.81M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out71.07M
Employees233
ListedFri, Feb 3, 2023
Free float23.17M
Float %32.6%
Short interest5.85M
Days to cover7.9d
Short volume24.6%
Squeeze score65 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.49 vs −$0.39
Last surprise-25.6% miss
Setup gradeD
Conviction8 / 100
Pattern quality—
Tech rank11.0 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance55.30
Support39.76
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Structure Therapeutics (GPCR) Gains Fresh Obesity Trial Backing Following Data That Keeps Valuation In FocusYahoo Finance · Tue, Sep 22, 2026
- VKTX, GPCR, ALT Stocks Rise: Novo Nordisk Signals Bigger M&A As It Chases Over 5 ‘Multi-Blockbusters’Stocktwits · Tue, Sep 22, 2026
Congress activity
Disclosed STOCK Act trades in GPCR
No recent disclosed trades by Congress in GPCR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in GPCR · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Lin Xichen CHIEF SCIENTIFIC OFFICER · Ordinary Shares · 2026-09-01 | Exercise | 17.82K | $6K | 2026-09-01 | 2026-09-02 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · Ordinary Shares · 2026-09-01 | Convert | 17.82K | — | 2026-09-01 | 2026-09-02 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · Share Option (right to buy) · 2026-09-01 | Exercise | 17.82K | — | 2026-09-01 | 2026-09-02 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · American Depositary Shares · 2026-09-01 | Convert | 5.94K | — | 2026-09-01 | 2026-09-02 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · American Depositary Shares · 2026-09-01 | Sell | 1.3K | $60K | 2026-09-01 | 2026-09-02 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · American Depositary Shares · 2026-09-01 | Sell | 4.54K | $214K | 2026-09-01 | 2026-09-02 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · American Depositary Shares · 2026-09-01 | Sell | 100 | $5K | 2026-09-01 | 2026-09-02 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · Ordinary Shares · 2026-08-18 | Exercise | 11.82K | $4K | 2026-08-18 | 2026-08-19 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · Ordinary Shares · 2026-08-18 | Convert | 11.82K | — | 2026-08-18 | 2026-08-19 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · Share Option (right to buy) · 2026-08-18 | Exercise | 11.82K | — | 2026-08-18 | 2026-08-19 |
SEC filings
EDGAR filings in GPCR · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.